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Pulsatile Hemodynamics and Outcomes in AHFS the research team members (S.H.S. and W.C.Y.), were eligible for the present study. Patients with cardiogenic shock and/or admitted to an intensive care unit were excluded. The investigation conformed to the principles outlined in the Declaration of Helsinki. A written informed consent approved by our institutional review board was obtained from each patient before enrollment.
Study protocol. Pulsatile hemodynamic measures and thoracic fluid content were obtained within 24 h of the hospitalization (first study), within 24 h before discharge (second study), and 2 weeks after discharge (third study), respectively. The caring physicians were blinded to the hemodynamic measurements to avoid interference with clinical managements. At the second hemodynamic study, comprehensive echocardiography and measuring of height, weight, and waist and hip circumferences were performed. Overnight fasting serum and plasma samples were also acquired for tests of creatinine (P Cr ) and NT-proBNP, respectively, on the day of the second hemodynamic study. Data of initial presentation at the emergency department (ER), medical history, demography, in-hospital pharmacological therapy, and postdischarge medications were recorded. Estimated glomerular filtration rate (eGFR) was calculated by a modified modification of diet in renal disease equation based on the Chinese population using the P Cr : eGFR (ml/min/1.73 m 2 ) = 175 × P Cr −1.234 × age −0.179 × (0.79 if female). 10 NT-proBNP was measured by an enzyme-linked immunosorbent assay microtiter plate (Roche Diagnostics, Basel, Switzerland). 11 Patients were studied under supine resting condition in a quiet, temperature-controlled room. After resting for at least 10 min, thoracic fluid content, an indicator of the total fluid volume in the chest, was determined by impedance cardiography (BioZ ICG Monitor; CardioDynamics, San Diego, CA) to evaluate the volume status. 12, 13 Supine brachial SBP and diastolic blood pressure, and simultaneous right common carotid and right femoral arterial waveforms were measured with a commercially available device using the oscillometric and arterial tonometric techniques (VP-2000; Colin, Komaki, Japan). 14 PP was the difference between SBP and diastolic blood pressure. cf-PWV was calculated from the foot-to-foot pulse transit time between right carotid and right femoral arteries, and the travelling distance that was the difference between the surface measurements from the suprasternal notch to the carotid and femoral pulse recording sites, respectively. 15, 16 Central SBP was the peak value of an ensemble averaged carotid artery pressure waveform calibrated with brachial diastolic and mean blood pressures. 8 The inflection point resulting from the wave reflection on the upstroke or downstroke of the carotid pressure waveform was identified by finding the zero-crossing timings of the fourth derivative of the pressure waveform. 17 cAI and cAP were calculated accordingly. 18 cAI 75 was the adjusted cAI to a heart rate of 75 beats/min by the formula: cAI 75 = ((heart rate -75) × 0.39) + cAI. 19, 20 A comprehensive Doppler and M-mode echocardiographic examination using a multifrequency transducer incorporated in a SONOS 5500 Echocardiograph (Hewlett Packard, Agilent Technologies, Andover, MA) was performed before discharge. LV mass indexed to body surface area and ejection fraction were calculated using the M-mode measurements. Patients with LV ejection fraction 45% were defined to have systolic heart failure. 21 Follow-up. All patients could be stabilized by medical therapy and discharged smoothly. They were followed up 2 weeks after discharge and then monthly at outpatient clinics or by telephone consultations to check whether there were any adverse cardiovascular events including rehospitalization for heart failure, nonfatal myocardial infarction, nonfatal stroke, and death for up to 6 months. Elevations in biomarkers were fundamental to the diagnosis of myocardial infarction according to the criteria issued by a Joint Committee of the European Society of Cardiology and the American College of Cardiology. 22 A neurologist made a clinical diagnosis of acute stroke and documented the presence of an acute, focal neurological deficit. These adverse cardiovascular events were confirmed by review of medical records by an independent investigator, who was blinded to the hemodynamic measurements. The period of event-free survival was defined as the interval between the second hemodynamic survey and the date of adverse events or the end of follow-up.
Statistical analysis. Means, s.d., and percentages were used to describe the characteristics of participants in the study. Student's t-test and χ 2 -test were used for between-group comparisons where appropriate. The post-hoc power of this study was calculated based on the 80 AHFS patients at an α value of 0.05, assuming no differences in clinical characteristics between those with (n = 29) and without (n = 51) events within 6 months of discharge. The serial changes of the hemodynamic measures were analyzed by repeated measures of the general linear model. Cox regression analysis was used to identify the predictors for future cardiovascular events. Significant predictors identified from the univariate analysis were further examined in the multivariate models by adjusting for age and NT-proBNP. The number of independent variables was limited to a maximum of three in the multivariate models due to the limited sample size and event rate in the present study. Collinearity in the multivariate Cox regression models was examined by calculating the variance inflation factor. No significant collinearity was found in any of the multivariate Cox regression models. Because of the skewed distribution, log transformation was performed for NT-proBNP before Cox regression analysis. The Kaplan-Meier method was used to estimate survival curves of cardiovascular events associated with the subgroups stratified on the basis of median values of central PP and NT-proBNP. The log-rank test was used to compare the unadjusted survival curves. All statistical significances were set at P < 0.05 and all statistical analyses were carried out by SPSS 15.0 (SPSS, Chicago, IL).
RESulTS
Totally, 98 patients were screened for the study. However, three patients died during the index hospitalization, seven original contributions Pulsatile Hemodynamics and Outcomes in AHFS had atrial fibrillation, and eight refused to participate or could not complete postdischarged examinations. The 80 eligible study patients were characterized with a mean age of 73.2 ± 14.1 years (range: 24-94 years), 82.5% of male sex, and 50% of systolic heart failure. During a follow-up of 174 ± 32 days (range 16-183 days), 29 (36.3%) patients incurred adverse events, including 20 rehospitalizations for heart failure, 3 nonfatal myocardial infarctions, 1 nonfatal strokes, and 5 mortalities. The baseline characteristics, predischarge echocardiographic findings, and postdischarge medications were similar in patients with and without a postdischarge adverse event within 6 months ( Table 1) . Patients with and without events had similar age, sex, body mass index, functional classification, comorbidities, and LV ejection fraction and LV mass index. On the other hand, patients with events had significantly higher plasma NT-proBNP levels than those without events.
Changes of fluid content, heart rate, and the pulsatile hemodynamics in AhFS patients with and without events within 6 months of discharge Thoracic fluid content was similar at admission and reduced significantly before discharge (all P < 0.05 when compared with baseline values in both groups), but without further reduction at 2 weeks after discharge in patients with and without events ( Table 2 and Figures 1 and 2) . The predischarge thoracic fluid content correlated significantly with plasma NT-proBNP (with log transformation, r = 0.449, P < 0.01). Heart rate was similar at ER in both groups and reduced significantly before discharge (P < 0.05).
The pulsatile hemodynamic measures at ER and at admission were also similar in patients with and without events ( Table 2 and Figures 1 and 2) . However, patients with events had significantly higher brachial and central PP, and cAP than those without events before discharge (Figures 1 and 2) . Two weeks after discharge, patients with events had significantly greater brachial and central SBP and PP, cAP, and cf-PWV than patients without events (Figures 1 and 2) . Except for cAP, most pulsatile hemodynamic measures, including brachial and central SBP and PP, and cf-PWV reduced progressively in patients without events but not in those with events (Figures 1 and 2) . By univariate analysis, predischarge NT-proBNP, central PP, and cAP, and postdischarge thoracic fluid content, brachial and central SBP and PP, cAI, cAP, and cf-PWV had significant predictive values for adverse postdischarge outcomes ( Table 3) . None of the comorbidities or postdischarge medications had significant predictive value except that the association of the use of β-blockers with reduced adverse events was borderline significant (hazard ratio and 95% confidence interval: 0.43 (0.18- ER, presentation in the emergent room; S1, first study, within 24 h of admission; S2, second study, within 24 h before discharge; S3, third study, after discharge. *Significant differences between groups at the individual study. P values are for trends over the four studies. ) carotid-femoral pulse wave velocity in acute heart failure syndrome patients with and without postdischarge adverse events. Solid circles indicate patients with events and empty circles indicate patients without events. S1, first study, within 24 h of admission; S2, second study, within 24 h before discharge; S3, third study, after discharge. *Significant differences between groups at the individual study. P values are for trends over the three studies.
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significantly predicted events in the dual-blood pressure stepwise multivariate Cox regression analysis (data not shown). Kaplan-Meier survival curves for high and low predischarge NT-proBNP (median value 2,066 pg/ml), predischarge central PP (median value 46 mm Hg), and postdischarge central PP (median value 42 mm Hg) are shown in Figure 3 . Combination of high NT-proBNP and high predischarge central PP predicted more events than either high NT-proBNP or high-central PP alone (Figure 3a) . Similarly, combination of high NT-proBNP and high postdischarge central PP had the lowest survival rate at 6 months (Figure 3b) . dISCuSSION The present study assessed comprehensively the pulsatile hemodynamics within 24 h of admission and predischarge, and during the early postdischarge phase in patients with AHFS. Although all of our patients improved symptomatically during hospitalization and were discharged in stable condition, their postdischarge rehospitalization and cardiovascular events rates remained high. 1 We observed that most pulsatile hemodynamic measures reduced significantly in patients without events but not in those with events. Patients experiencing postdischarge events showed incomplete recovery of the pulsatile hemodynamic perturbations in the predischarge and early postdischarge phases. Predischarge central PP and cAP, and early postdischarge brachial and central SBP and PP, cAP, and cf-PWV were associated with the short-term postdischarge outcomes independently of the predischarge NT-proBNP levels. Therefore, the study provides the clinical evidence that perturbations of the pulsatile hemodynamics may be involved in both the precipitation of AHFS and the postdischarge rehospitalization and cardiovascular events.
Pulsatile hemodynamics and the development of heart failure
Increased arterial stiffness is a direct manifestation of vascular aging 23 and is an independent predictor of heart failure in the elderly and in hypertensives. 5, 24 Advancing age and female gender are associated with increases in arterial and ventricu- cAI, carotid augmentation index; cAI 75 , carotid augmentation index with adjustment to heart rate 75 beats/min; cAP, carotid augmented pressure; cf-PWV, carotid-femoral pulse wave velocity; CI, confidence interval; NT-proBNP, N-terminal pro-brain natriuretic peptide; PP, pulse pressure; SBP, systolic blood pressure. Accounting for age and NT-proBNP. cAI, carotid augmentation index; cAP, carotid augmented pressure; cf-PWV, carotid-femoral pulse wave velocity; CI, confidence interval; NT-proBNP, N-terminal pro-brain natriuretic peptide; PP, pulse pressure; SBP, systolic blood pressure.
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Pulsatile Hemodynamics and Outcomes in AHFS lar stiffness, and this combined ventricular-arterial stiffening may contribute to the development of heart failure with preserved ejection fraction. 25 Increased arterial wave reflections assessed by cAI, cAI 75 , or cAP impose a late systolic load on the left ventricle, with impairment of early diastolic relaxation function, 26, 27 and elevation of B-type natriuretic peptide. 28 The potential importance of wave reflection in the pathogenesis of heart failure has been emphasized. 26 Both brachial SBP and PP are augmented by arterial wave reflections, especially with advancing age and increasing arterial stiffening. 29, 30 Hypertension is a well-recognized principal precursor of heart failure and brachial SBP and PP confer greater risk for the development of heart failure than diastolic blood pressure in the general population and hypertensive patients. 31 On the other hand, the role of central SBP and PP in the development of heart failure remains poorly defined. In the communitybased Framingham Heart Study, cf-PWV but not cAI, central PP or carotid-brachial pulse pressure amplification was independently associated with increased risk for a first cardiovascular event including heart failure. 16 
Perturbations of the pulsatile hemodynamics in AhFS
In patients with chronic heart failure, individual components of the pulsatile hemodynamics may be elevated or reduced when compared to controls, 6, 32, 33 and the global measures may appear normal possibly because of contrasting changes in central and peripheral conduit vessels. 32 In contrast, the role of pulsatile hemodynamics in the pathogenesis of AHF remains incompletely understood. A substantial elevation in SBP is present in the majority of patients with acute heart failure, including those with preserved systolic function. 34, 35 Elevated arterial stiffness may precipitate AHFS through acute elevation of SBP that exacerbates diastolic function. 34, [36] [37] [38] Our results supported this hypothesis by showing the progressive parallel reduction of brachial and central SBP and PP, and cf-PWV during the hospital course and the early discharge period in patients without events. In 72 stable heart failure patients with an averaged LV ejection fraction of 53%, elevated arterial stiffness evaluated by brachial-ankle PWV was a risk factor for rehospitalization or mortality. 36 Our results further extended that insufficient reduction of the pulsatile hemodynamic measures may indicate suboptimal treatment of acute heart failure and may predict events including rehospitalization for heart failure, nonfatal myocardial infarction, nonfatal stroke, and death after discharge.
Prognostic value of central PP in AhFS
Brachial SBP at hospital admission has been an important and independent predictor of morbidity and mortality in patients with AHFS. 35, 39 Low brachial SBP at admission was thought to be associated with adverse cardiovascular events in AHFS. 35, 40 However, the predictive values of the sequential changes of central and brachial SBP and PP have not been explored. A low brachial SBP at ER might indicate the presence of an unstable hemodynamics, for which intensive care was usually warranted. Because we excluded patients admitted to intensive care units, the brachial SBP at ER did not correlate with short-term postdischarge outcomes in this study. In addition, the predictive values of the pulsatile hemodynamic measures within 24 h of admission were not significant and were likely confounded by the use of the intravenous vasodilators or inotropes for the management of AHFS. On the other hand, our results demonstrated the parallel reduction of central SBP and PP with brachial SBP and PP in patients without postdischarge events. Moreover, the predischarge and early postdischarge central PP might be more important than central SBP or peripheral PP in the prediction of postdischarge events.
limitations of the present study
The intensive medical treatments usually start at ER to rapidly reduce pulmonary capillary wedge pressure and systemic vascular resistance and to increase cardiac output in AHFS patients. In the present study, the first pulsatile hemodynamic examination was performed within 24 h after hospitalization. Therefore, except for the initial brachial blood pressure at ER, we did not capture the real at-admission pulsatile hemodynamic measures that had not been confounded by any medical treatments. 34 However, our results suggested that the predischarge and early after-discharge pulsatile hemodynamics are more useful than those measured at admission in the prediction of short-term outcomes. During the presentation with AHFS, estimated glomerular filtration rate is likely affected by the unstable hemodynamic status and the antiheart failure treatments (diuretics, angiotensin-converting enzyme inhibitor, β-blocker, etc.). Therefore, the predischarge estimated glomerular filtration rate might not represent the patient's usual renal function status. Our study subjects had sinus rhythm and relative stable conditions. The presented findings should be confirmed in patients with atrial fibrillation or more severe conditions that require critical care. The predischarge brachial SBP was 7 mm Hg higher, and the central SBP was 9 mm Hg higher in patients with events, yet these were not 
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Pulsatile Hemodynamics and Outcomes in AHFS statistically significant (Figures 1 and 2 ). These were probably the results of insufficient power (calculated values of power for the predischarge brachial and central SBP were 0.44 and 0.79, respectively) to detect a difference, due to the limited sample size and number of events in the present study. The independent prognostic values of the pulsatile hemodynamics in specific subgroups (such as patients with and without preserved ejection fraction) need further verifications in future studies with sufficient sample size and event rate.
In conclusion, pulsatile hemodynamics resulting mainly from the arterial stiffening and wave reflection phenomenon are involved in the development and progression of AHFS. Suboptimal recovery of the pulsatile hemodynamics, such as cPP and cAP, may predict short-term postdischarge cardiovascular outcomes in patients hospitalized due to AHFS, independently of NT-proBNP levels. Future interventional studies are required to investigate whether aggressive therapies targeting on the pulsatile hemodynamics reduce future cardiovascular events in patients with AHFS.
